Influence of the traditional Brazilian drink Ilex paraguariensis tea on glucose homeostasis  by Pereira, D.F. et al.
I
h
D
E
a
b
c
d
a
K
I
G
I
D
G
D
I
g
s
m
a
e
p
i
r
B
8
f
0
hPhytomedicine 19 (2012) 868– 877
Contents lists available at SciVerse ScienceDirect
Phytomedicine
jou rn al hom epage: www.elsev ier .de /phymed
nﬂuence  of  the  traditional  Brazilian  drink  Ilex  paraguariensis  tea  on  glucose
omeostasis
.F.  Pereiraa,  V.D.  Kappela, L.H.  Cazarolli b, A.A.  Boligonc,  M.L.  Athaydec, S.M.  Guessera,
.L. Da  Silvad, F.R.M.B.  Silvaa,∗
Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Cx. Postal 5069, CEP: 88040-970 Florianópolis, SC, Brazil
Universidade Federal da Fronteira Sul, Campus Universitário Laranjeiras do Sul, Bairro Vila Alberti, CEP: 85303-775 Laranjeiras do Sul, PR, Brazil
Departamento de Farmácia Industrial, Universidade Federal de Santa Maria, Campus Camobi, RS, Brazil
Departamento de Análises Clínicas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil
 r  t  i  c  l  e  i  n  f  o
eywords:
lex paraguariensis
lycemia
nsulin
iabetes
lycation
isaccharidase
a  b  s  t  r  a  c  t
In  this  study  we  examined  the  acute  in  vivo  effect  and  short-  and  long-term  in  vitro effects  of  samples
from  native  and  commercial  Ilex paraguariensis  on glucose  homeostasis.  Also,  the  potential  effect  of  I.
paraguariensis  on  serum  insulin  secretion  was  investigated.  The  chemical  identiﬁcation  and  quantiﬁca-
tion  of  methyl  xanthines  and  polyphenols  in  CH2Cl2, EtOAc  and  n-BuOH  fractions  of native  I.  paraguariensis
as  well  as  infusions  of  green  and  roasted  I.  paraguariensis  from  a commercial  source  was  veriﬁed  by  high-
performance  liquid  chromatography.  The  results  for  the  serum  glucose-lowering  indicated  that  both
fractions  and  both  infusions  were  able  to  improve  signiﬁcantly  the  oral  glucose  tolerance  curve.  Addi-
tionally,  both  the  EtOAc  and  n-BuOH  fractions  induced-insulin  secretion,  but  EtOAc  induced  an early  (at
15 min)  and  late  (at  60 min)  biphasic  peak  of  insulin  secretion  similar  to  glipizide  stimulatory  effect.  Both
fractions  increased  liver  glycogen  content  compared  with  fasted  normal  rats. Also,  EtOAc  and  n-BuOH
fractions  inhibited  in  vitro  disaccharidases  activities  after  an acute  treatment.  The  maximum  inhibitory
effect  of  the  EtOAc  and  n-BuOH  fractions  on maltase  activity  (at  5  min)  was  around  35%. The  evident
reduction  of  protein  glycation  by  glucose  or  fructose  with  EtOAc  and  n-BuOH  fractions  increased  from  7
to  28  days  of  in  vitro  incubation.  Inhibition  of  bovine  serum  albumin  glycation  by glucose  and  fructose,
by  around  50%  and 90%,  respectively,  was  observed.  Additionally,  the  green  and  roasted  mate  infusions
reduced  the formation  of  AGEs  in  a characteristic  long-term  effect.  In conclusion,  this  study  shows  that  I.
paraguariensis  has  an  anti-hyperglycemic  potential  role  able  to improve  the  diabetic  status  and  is  probably
glycea  source  of  multiple  hypo
ntroduction
Ilex paraguariensis (St. Hill, Aquifoliaceae), a perennial tree that
rows in Southern Brazil, Paraguay and Argentina, is used to make a
timulating drink called chimarrão,  tererê,  or mate. This drink, com-
only consumed in the cold regions of South America, is prepared
s a hot infusion from dry, ground leaves or stemlets. Another bev-
rage appreciated for its pleasant aroma is black or milk mate tea
repared with dry or ground and roasted leaves from I. paraguar-
ensis consumed daily as a typical hot tea or in the form of refreshing
eady-to-drink iced mate tea (Bracesco et al. 2011).
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A large number of crude extracts and puriﬁed substances
obtained from plants have been extensively assayed in experimen-
tal tests in order to identify new active substances with potential for
antidiabetic treatments (Silva et al. 2002; Luceford and Gugliucci
2005; Zanatta et al. 2007; Cazarolli et al. 2008; Folador et al. 2010).
Phytochemical characterization has shown that compounds like
C- and/or O-glycosilated ﬂavonoids (Zanatta et al. 2008; Cazarolli
et al. 2009; Folador et al. 2010), as well as analogs synthesized
using a natural compound as a prototype, chalcones (Alberton
et al. 2008) and d-gluconic acid complexed with the trace element
vanadium (Guiotoku et al. 2007) are effective in serum glucose-
lowering in diabetic rats. Also, these compounds exhibit powerful
action in improving the glucose tolerance curve, increasing serum
Open access under the Elsevier OA license. insulin secretion, inhibiting the formation of advanced glycation
end-products, stimulating glucose uptake and glycogen synthe-
sis in soleus muscle and acutely inhibiting -glycosidase activity
in the duodenum portion of the intestine (Pereira et al. 2011).
Diabetes mellitus (DM) is a chronic disease caused by inherited
medic
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time with those of a reference standard and quantiﬁcation was per-
formed by peak integration using the external standard method.D.F. Pereira et al. / Phyto
nd/or acquired deﬁciency in pancreatic insulin production or by
he ineffectiveness of the insulin produced (Matthaei et al. 2000).
he treatment of type 2 diabetes is complicated by several fac-
ors inherent to the disease process, such as insulin resistance,
yperinsulinemia, impaired insulin secretion and reduced insulin-
ediated glucose uptake and utilization (Cazarolli et al. 2008).
esides the drugs traditionally used for the treatment of dia-
etes (insulin, sulphonylureas, biguanides and thiazolidinediones),
everal species of plants have been described in the scientiﬁc
nd popular literature as having hypoglycemic activity (Cazarolli
t al. 2008). Because of their perceived effectiveness, minimal
ide effects in clinical experience and popular belief, herbal drugs
re widely prescribed even when their biologically active com-
ounds are unknown (Fröde and Medeiros 2007; Baldea et al. 2010).
lthough extracts or infusions of the leaves of I. paraguariensis
ave been reported to exhibit antioxidant activity, an inhibitory
ffect on glucose absorption and inhibition of advanced glyca-
ion end-products formation, there are no reports in the literature
oncerning the mechanisms involved in the short and long-term
ffects of this plant in ameliorating the hyperglycemic status. The
resent study investigated the acute in vivo effect and short- and
ong-term in vitro effect of samples from native and commercial I.
araguariensis on glucose homeostasis. Also, the potential effect of
. paraguariensis on one of the best endogenous glucose regulators,
nsulin secretion, was investigated.
aterials and methods
hemicals
Glipizide, glycogen, serum bovine albumin, gallic acid, chloro-
enic acid, caffeic acid, caffeine, theobromine, quercetin, catechin,
−)epigallocatechin and (−)epigallocatechin gallate were pur-
hased from Sigma–Aldrich Chemical Company® (St. Louis, MO,
SA). Glucose, fructose, maltose and all other solvents were pur-
hased from Diprolab® (Florianópolis, SC, Brazil). Solvents for the
nalytical procedures, ethanol, and methanol were purchased from
erck (Darmstadt, Germany). All chemicals were of analytical
rade. The enzyme-linked immunosorbent assay (ELISA) for the
uantitative determination of rat insulin (catalog no. EZRMI-13K)
as purchased from Millipore (St. Charles, MO,  USA).
lant material
The leaves were collected at the Federal University of Santa
aria (Santa Maria, RS, Brazil). Native leaves collected were iden-
iﬁed as authentic I. paraguariensis by Prof. Dr. Gilberto Dolejal
anetti and archived as a voucher specimen (HDFI no. 243) in the
erbarium of the Industrial Pharmacy Department of the Federal
niversity of Santa Maria. The leaves of commercial green and
oasted yerba mate were purchased from Leão Junior SA (Curitiba-
R, Brazil). A specimen of the plant was identiﬁed as authentic I.
araguariensis in the Botanical Department of the Federal Univer-
ity of Santa Catarina by Prof. Dr. Daniel de Barcelos Falkenberg.
reparation of extract, fractions and infusions of I. paraguariensis
The native leaves of the plant from Santa Maria were dried at
oom temperature and powdered in a knife mill. The leaf pow-
er was macerated at room temperature with 70% ethanol for
ne week with daily shaking. After ﬁltration, the extract was
vaporated under reduced pressure to remove the ethanol. The
xtract was suspended in water and partitioned successively with
ichloromethane, ethyl acetate (EtOAc) and n-butanol (n-BuOH)
3 ml  ×200 ml  for each solvent). Infusions of yerba mate were pre-
ared by mixing boiling water and dried and minced leaves of the
ommercial yerba mate (green or roasted mate) in the proportionsine 19 (2012) 868– 877 869
of 50, 100 and 200 mg/ml. After 10 min  of extraction, the mixture
was  ﬁltered and administrated immediately to rats.
Determination of total phenolic content
The determination of total phenolic content was  performed by
the Folin–Ciocalteu method with slightly modiﬁcations (Boligon
et al. 2009). Brieﬂy, 0.5 ml of 2 N Folin–Ciocalteu reagent was
added to a 1 ml  for each sample (0.083 mg/ml) and this mixture
was  allowed to stand for 5 min  before the addition of 2 ml  of
20% Na2CO3. The solution was then allowed to stand for 10 min
before reading at 730 nm in a Shimadzu-UV-1201 (Shimadzu,
Kyoto, Japan) spectrophotometer. The total phenolic content was
expressed in milligrams equivalents of gallic acid (GAE) per gram of
each fraction. The equation obtained for the calibration curve of gal-
lic acid in the range of 0.005–0.030 mg/ml  was Y = 11.969 − 0.0454
(r = 0.9984).
Chromatographic conditions
High performance liquid chromatography (HPLC-DAD) was per-
formed on an HPLC system (Shimadzu, Kyoto, Japan), with a
Prominence Auto-Sampler (SIL-20A), equipped with Shimadzu LC-
20 AT reciprocating pumps connected to the degasser DGU 20A5
with an integrator CBM 20A, UV–Vis detector DAD SPD-M20A
and Software LC solution 1.22 SP1. Chromatographic analy-
sis of theobromine, caffeine, and gallic, chlorogenic and caffeic
acids were carried out under isocratic conditions using an RP-
C8 column (4.5 mm × 150 mm,  I.D. 5 m).  The mobile phase was
methanol–water (25:75, v/v). The ﬂow rate was  0.5 mL/min, injec-
tion volume 20 l and wavelength 280 nm.  The mobile phase was
ﬁltered through a 0.45 m membrane ﬁlter and then degassed
ultrasonically before use. The solutions of the standards (theo-
bromine, caffeine, gallic, chlorogenic and caffeic acids) were
prepared in the same mobile phase as in the HPLC (Reginatto
et al. 1999). Standard calibration curves were constructed in
the concentrations of 0.1, 0.05, 0.025, 0.0125, 0.00625 mg/ml.
The chromatographic peaks were conﬁrmed by comparing the
retention time with those of reference standards and quantiﬁ-
cation was  performed by peak integration using the external
standard method. The calibration curve were, theobromine:
y = 188800x − 1686.5 (r = 0.9908); caffeine: y = 114352x − 1002.7
(r = 0.9872), gallic acid: y = 329417x − 1452.1 (r = 0.9996), chloro-
genic acid: y = 456630x − 1705.9 (r = 0.9989) and caffeic acid:
y = 278549x − 1150.7 (r = 0.9999).
The determination of quercetin, catechin, (−)epigallocatechin
and (−)epigallocatechin gallate were performed in reversed-phase
using a C18 column (4.6 mm × 250 mm)  packed with 5 m diam-
eter particles. The mobile phase was solvent A, water–formic
acid (99.7:0.3 v/v), and solvent B, methanol–formic acid (99.7:0.3
v/v), with 70–50% A in 10 min  and 50–30% A in 20 min, always
in a linear gradient. The ﬂow rate was 1.0 ml/min, injec-
tion volume 20 l and wavelength 370 nm for quercetin and
280 for catechin, (−)epigallocatechin and (−)epigallocatechin
gallate (Matsubara and Rodriguez-Amaya 2006). The stan-
dard calibration curve was constructed in the concentrations
of 0.2, 0.1, 0.05, 0.250, 0.0125 mg/ml  for quercetin, catechin,
(−)epigallocatechin and (−)epigallocatechin gallate. The chro-
matographic peaks were conﬁrmed by comparing the retentionThe calibration curve were, quercetin: y = 30153x  −23513.5
(r = 0.9983), catechin y = 29013x  − 1158.4 (r = 0.9998), epigallocat-
echin y = 23895x  − 1697.9 (r = 0.9997) and epigallocatechin gallate
y = 21744x  −1860.2 (r = 0.9998). All chromatographic operations
were performed at room temperature and in triplicate.
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nimals
Male Wistar rats (180–200 g) were used. These were bred in our
nimal facility and housed in an air-conditioned room (approxi-
ately 21 ± 2 ◦C) with a controlled 12:12 h light/dark cycle (lights
n from 06:00 to 18:00 h). The animals were maintained with pel-
eted food (Nuvital, Nuvilab CR1, Curitiba, PR, Brazil) and tap water
as available ad libitum.  Fasted animals were deprived of food for
t least 16 h but allowed free access to water. All the animals were
onitored and maintained in accordance with the ethical recom-
endations of the Brazilian Veterinary Medicine Council (CMV) and
he Brazilian College of Animal Experimentation (COBEA). Protocol
P00187 and PP00414/CEUA/UFSC.
ral glucose tolerance curve
Fasted rats were divided into six groups of six animals: group
, euglycemic control rats; group II, rats receiving glucose (4 g/kg;
.9 M);  group III, rats receiving glucose (4 g/kg) plus EtOAc fraction
100 and 200 mg/kg); and group IV, rats receiving glucose (4 g/kg)
lus n-BuOH fraction (100 and 200 mg/kg); group V, rats receiving
lucose (4 g/kg) plus aqueous extract of green mate infusion (50,
00 and 200 mg/ml); group VI, rats receiving glucose (4 g/kg) plus
queous extract of roasted mate infusion (50, 100 and 200 mg/ml)
f I. paraguariensis.  Blood samples from the tail vein were collected
t zero, 15, 30, 60 and 180 min  after glucose loading. All in vivo treat-
ents were made orally by gavages (De Sousa et al. 2004; Zanatta
t al. 2007).
etermination of the plasma glucose concentration
Blood samples were collected and centrifuged, and the blood
lucose levels were determined by the glucose oxidase method
Varley et al. 1976; De Sousa et al. 2004).
nsulin serum measurements
The insulin levels were measured by enzyme-linked
mmunosorbent assay (ELISA) according to the manufacturer’s
nstructions. The range of values detected by this assay was:
.2–10 ng/ml. The intra- and inter-assay coefﬁcients of variation
CV) for insulin were 3.22 and 6.95, respectively, with a sensi-
ivity of 0.2 ng/ml. All insulin levels were estimated by means of
olorimetric measurements at 450 nm with an ELISA plate reader
Organon Teknika, Roseland, NJ, USA) by interpolation from a
tandard curve. Samples were analyzed in duplicate and results
ere expressed as ng of insulin serum mL−1 (Cazarolli et al. 2009).
lycogen content measurements
Livers were harvested from the untreated hyperglycemic rats
control), treated with EtOAc and n-BuOH fractions (200 mg/kg)
nd used for the assay of glycogen content immediately after 3 h of
reatment. Glycogen was isolated from this tissue as described by
risman (1962),  with minor modiﬁcations (Folador et al. 2010). The
issue was weighed, homogenized in 33% KOH and boiled at 100 ◦C
or 20 min, with occasional stirring. After cooling, 96% ethanol was
dded to the samples which were then heated to boiling followed
y cooling in an ice bath to aid the glycogen precipitation. The
omogenate was centrifuged at 1300 × g for 15 min, the super-
atant was discarded and the pellet was neutralized with saturated
H4Cl before being heated to 100 ◦C for 5 min, washed and resol-
bilized in water. Glycogen content was determined by treatment
ith iodine reagent and the absorbance was measured at 460 nm.
he results were expressed as mg  of glycogen/g of tissue.isaccharidase extraction and assays
A segment of the small intestine was removed, washed in 0.9%
aCl solution, dried on ﬁlter paper, weighed, trimmed and homog-
nized (300 rpm) with 0.9% NaCl (400 mg  of duodenum per ml)  forine 19 (2012) 868– 877
1 min  at 4 ◦C. The resulting extract was  centrifuged at 8000 rpm for
8 min. The supernatant was  used for the measurement of in vitro
maltase, sucrase and lactase activities and protein determination
(Pereira et al. 2011).
Maltase (EC 3.2.1.20), lactase (EC 3.2.1.23) and sucrase (EC
3.2.1.48) activities were determined using a glucose diagnosis kit
based on the reagent glucose oxidase. For determination of the dis-
accharidase activity 50 l of homogenate were pre-incubated at
37 ◦C for 5 min, in the absence (control) or in the presence of the
EtOAc or n-BuOH fractions of I. paraguariensis (treated). The concen-
trations of 500, 1000 and 1500 g/ml were used for each fraction.
The duodenum homogenates were then incubated at 37 ◦C for 5 min
with 25 l of the substrate (corresponding to 0.056 M of maltose,
sucrose or lactose) (Dahlqvist 1984; Pereira et al. 2011).
One enzyme unit (U) was deﬁned as the amount of enzyme that
catalyzed the release of 1 mol  of glucose per min under the assay
conditions. The speciﬁc activity was  deﬁned as enzyme activity (U)
per mg  of protein. Protein concentration was determined by the
method described in Lowry et al. (1951) using bovine serum albu-
min  as the standard. The assays were performed in duplicate and
conducted along with appropriate controls.
Formation of advanced glycation end-products in the bovine
serum albumin/glucose and fructose systems
Advanced glycation end-products (AGEs) were formed in in vitro
systems using a previously described method (Kiho et al. 2004).
In brief, bovine serum albumin (BSA) (10 mg/ml) in phosphate
buffered-saline (PBS, pH 7.4) containing 0.02% sodium azide was
incubated with glucose (500 mM)  at 37 ◦C for 0, 7, 14 and 28 days
in the absence (control) and presence of EtOAc or n-BuOH fractions
(2.5–5.0 g/ml), or green or roasted mate infusions (2.5–5.0 g/ml).
BSA (5 mg/ml) was  also incubated with fructose (100 mM)  in PBS
(pH 7.4) containing 0.02% sodium azide at 37 ◦C. Each solution was
kept in the dark in a capped vial, and incubation was allowed to pro-
ceed in triplicate vials. For time-course studies, the AGE formation
was  measured according to the characteristic ﬂuorescence (exci-
tation wavelength of 370 nm and emission wavelength of 440 nm)
with Inﬁniti M200 (TECAN).
Data and statistical analysis
Data were expressed as means ± S.E.M. One-way analysis of
variance (ANOVA) followed by Bonferroni post-test or unpaired
Student’s t-test were used to determine the signiﬁcant difference
between the groups. Differences were considered to be signiﬁcant
at p ≤ 0.05.
Correlation coefﬁcients (r) to determine the relationship
between two  variables and the standard deviations for methyl
xanthines and polyphenols assays were calculated from the data
obtained from three separate experiments using MS  Excel for Win-
dows.
Results
Phytochemical analysis in CH2Cl2, EtOAc and n-BuOH fractions of
native I. paraguariensis of Santa Maria and of commercial sources
Table 1 shows that the majority of phenolic content are dis-
tributed into the polar fractions. Also, as it can be seen, into
the infusions there is no difference on phenolic content between
roasted and green samples, in this experimental condition.
Table 2 and Fig. 1 show the concentration of methyl xanthines
(caffeine and theobromine), quercetin, gallic acid, chlorogenic acid,
caffeic acid, catechin, (−)epigallocatechin and (−)epigallocatechin
gallate in the CH2Cl2, EtOAc and n-BuOH fractions and green and
D.F. Pereira et al. / Phytomedicine 19 (2012) 868– 877 871
Fig. 1. HPLC chromatograms of CH2Cl2, EtOAc and n-BuOH fractions and green and roasted infusions of Ilex paraguariensis by methods 1 and 2. Peaks means: (1) caffeine, (2)
theobromine, (3) gallic acid, (4) chlorogenic acid, (5) caffeic acid, (6) catechin, (7) epigallocatechin, (8) epigallocatechin gallato and (9) quercetin.
872 D.F. Pereira et al. / Phytomedic
Table 1
Total phenols content by the Folin–Ciocalteu method for roasted and green infusions
and  fractions of IP. Results are expressed as means ± S.E.M., n = 3 in triplicates.
I. paraguariensis Phenolica ± S.E.M. (mg/g)
Roasted 277.10 ± 0.012
Green 271.08 ± 0.003
CH2Cl2 96.82 ± 0.005
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glipizide group at 60 min. Moreover, the n-BuOH fraction potenti-
T
D
E
nEtOAc 209.91 ± 0.013
n-BuOH 193.24 ± 0.002
a Phenolic expressed as gallic acid equivalents (mg/g fraction).
oasted infusions. The n-BuOH fraction had higher contents of both
ethyl xanthines compared with the EtOAc fraction.
Quercetin presented a similar content in the EtOAc fraction of
he native I. paraguariensis processed in the laboratory (from Santa
aria) and both the green and roasted infusions from the com-
ercial source (Leão Junior SA). In addition, the contents of methyl
anthines in green and roasted yerba mate are slightly different.
he caffeine contents in the n-BuOH fraction and roasted infusion
re similar and theobromine was mainly found in the n-BuOH frac-
ion.
The proﬁle of the main polyphenols (catechin, epigallocat-
chin, epigallocatechin gallate and further procyanidins) of I.
araguariensis extract and infusions (green and roasted) analyzed
y HPLC-ﬁngerprint and quantiﬁed showed signiﬁcant presence
f chlorogenic acid in all samples studied. The high amount of
atechin was found on EtOAc fraction and green infusion. In addi-
ion, it was detected a high content of (−)epigallocatechin and
−)epigallocatechin gallate on EtOAc fraction, CH2Cl2 fraction and
reen and roasted infusions.
cute effect of EtOAc, n-BuOH fractions of native I. paraguariensis,
reen and roasted mate infusions of commercial I. paraguariensis
n oral glucose tolerance curve
Table 3 shows that the EtOAc fraction (200 mg/kg) caused a
igniﬁcant acute antihyperglycemic effect when compared to the
espective hyperglycemic control group (Group II). Serum glucose-
owering was detected at 15, 30 and 60 min  after oral treatment and
he glycemic reductions were around 29%, 28% and 21%, respec-
ively.
The n-BuOH fraction showed a similar proﬁle for the serum
lucose-lowering to that observed for the EtOAc fraction, with a
igniﬁcant decrease in serum glucose levels at 15, 30 and 60 min  of
able 2
etermination of caffeine, theobromine, quercetin, gallic acid, chlorogenic acid, caffeic aci
tOAC  and n-BuOH fractions of native I. paraguariensis and infusions of green and roasted
 = 3 in triplicates.
I. paraguariensis CH2Cl2 EtOAc 
Caffeine
mg/g 12.3 ± 0.2 1.8 ± 0.1 
%  1.23 0.18 
Theobromine
mg/g 11.7 ± 0.5 1.3 ± 0.2 
%  1.17 0.13 
Quercetin
mg/g 3.2 ± 0.2 2.0 ± 0.3 
%  0.32 0.20 
Gallic acid
mg/g 0.16 ± 0.1 0.25 ± 0.4 
%  0.01 0.02 
Chlorogenic acid
mg/g 2.94 ± 0.3 4.8 ± 0.1 
%  0.29 0.48 
Caffeic acid
mg/g 0.027 ± 0.2 0.028 ± 0.3
%  0.003 0.003 
Catechin
mg/g 2.58 ± 0.2 4.89 ± 0.3 
%  0.25 0.48 
(−)Epigallocatechin mg/g 10.83 ± 0.3 5.70 ± 0.5 
% 1.08 0.57 
(−)Epigallocatechin
gallate
mg/g 6.403 ± 0.2 9.02 ± 0.1 
% 0.64  0.90 ine 19 (2012) 868– 877
around 17, 25 and 18% when compared with the hyperglycemic
control group (Group II), respectively. However, the treatment
of hyperglycemic rats with 100 mg/kg of the n-BuOH or EtOAc
fractions only slightly reduced glycemia (around 12%) at 15 and
60 min, respectively. In addition, the EtOAc and n-BuOH fractions
(200 mg/kg) were studied in diabetic rat models and no signiﬁ-
cant changes in the blood glucose levels were observed (data not
shown). Also, the dichloromethane fraction was assayed using the
same approach and the 200 mg/kg dose slightly reduced the serum
glucose level by 13 and 19% at 15 and 60 min, respectively (data not
shown).
The acute effect of green mate infusion was a signiﬁcant
serum glucose-lowering in a dose-dependent manner. The use of
200 mg/kg of green mate infusion improved the glucose tolerance
curve more efﬁciently compared with 50 and 100 mg/kg. How-
ever, in pharmacologically induced-diabetic rats, no inﬂuence on
the serum glucose levels was detected with 200 mg/kg of green
and roasted mate infusion (data not shown). Although the roasted
mate infusion altered the serum glucose levels at all doses studied
in hyperglycemic rats, the best hypoglycemic effect was  observed
with the 100 mg/kg treatment. Additionally, the green mate infu-
sion was  apparently more efﬁcient in reducing the serum glucose
levels compared with the roasted mate infusion under these exper-
imental conditions.
Studies on the effect of EtOAc and n-BuOH fractions of native I.
paraguariensis on serum insulin secretion
Serum insulin levels were determined in fasted rats after an oral
glucose loading (4 g/kg) as shown in Table 4.
Glucose induced insulin secretion increased by 30% at 30 min
in hyperglycemic rats when compared with the euglycemic con-
trol group (zero time), returning to the basal levels at 60 min. As
expected, a sulphonylurea agent, glipizide, stimulated the insulin
secretion by around 194, 50 and 90% at 15, 30 and 60 min when
compared to the hyperglycemic control group, respectively. EtOAc
potentiated insulin secretion induced by glucose at 15 (100%) and
60 min  (200%) after oral treatment. In addition, EtOAc increased
signiﬁcantly insulin secretion by around 65% compared with theated the glucose effect on insulin secretion only at 60 min (150%).
Finally, the n-BuOH fraction was able to increase serum insulin
levels by around 35% only at 60 min  compared with the glipizide
group.
d, catechin, (−)epigallocatechin and (−)epigallocatechin gallate contents of CH2Cl2,
 commercial samples of I. paraguariensis. Results are expressed as means ± S.E.M.,
n-BuOH Green infusion Roasted infusion
5.4 ± 0.2 3.5 ± 0.4 5.7 ± 0.2
0.44 0.35 0.57
5.9 ± 0.3 1.4 ± 1.3 1.8 ± 0.7
0.59 0.14 0.18
1.2 ± 0.2 1.9 ± 0.3 2.1 ± 0.1
0.12 0.19 0.21
0.10 ± 0.3 0.14 ± 0.1 0.21 ± 0.5
0.01 0.01 0.02
3.05 ± 0.2 5.73 ± 0.5 6.17 ± 0.1
0.30 0.57 0.61
 0.015 ± 0.1 0.033 ± 0.2 0.042 ± 0.1
0.002 0.003 0.004
1.06 ± 0.1 3.65 ± 0.4 1.74 ± 0.3
0.10 0.36 0.17
1.99 ± 0.4 16.72 ± 0.3 20.83 ± 0.3
0.19 1.67 2.08
2.14 ± 0.1 34.19 ± 0.1 47.12 ± 0.2
0.21 3.41 0.47
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Table 3
Acute effect of EtOAc and n-BuOH fractions and green and roasted infusions of I. paraguariensis on glucose tolerance curve. Values are expressed as means ± S.E.M.; n = 6 in
duplicate.
Group Treatment Dose Time (min)
0 15 30 60 180
Group I (Normal) Vehicle 95.5 ± 1.3 121.2 ± 3.7 127.7 ± 3.5 126.5 ± 2.4 115.0 ± 3.0
Group  II (Control) Glucose 114.0 ± 2.0 170.7 ± 3.2 191.2 ± 4.5 169.7 ± 3.1 128.5 ± 6.9
Group  III EtOAc fraction
(mg/kg)
100 127.3 ± 2.3 167.1 ± 3.4 177.2 ± 0.8 150.4 ± 3.9* 141.6 ± 2.9
200  117.2 ± 4.0 122.1 ± 3.2*** 137.2 ± 3.0*** 133.7 ± 4.0*** 129.0 ± 3.6
Group  IV n-BuOH fraction
(mg/kg)
100 105.0 ± 5.2 151.2 ± 4.6* 189.7 ± 2.7 162.7 ± 7.2 141.0 ± 4.4
200  120.4 ± 2.8 142.7 ± 9.2*** 144.7 ± 5.8*** 140.9 ± 3.0*** 138.7 ± 3.7
Group  V Green infusion
(mg/ml)
50 100.3 ± 1.1 145.9 ± 7.0*** 178.6 ± 3.6 165.4 ± 3.7 129.5 ± 1.5
100 110.4 ±  2.9 156.2 ± 2.8** 170.9 ± 2.3* 149.4 ± 2.8*** 117.4 ± 2.6
200 105.4 ± 1.3 129.3 ± 3.8*** 155.6 ± 4.4*** 139.6 ± 5.6*** 126.3 ± 4.8
Group  VI Roasted infusion
(mg/ml)
50 106.5 ± 2.2 156.8 ± 4.9* 183.1 ± 5.1 157.1 ± 7.2 125.2 ± 4.1
100  104.3 ± 2.7 142.8 ± 4.5*** 164.8 ± 3.7*** 166.2 ± 4.4 143.7 ± 3.3
200  107.3 ± 1.5 161.9 ± 5.9 168.4 ± 2.7* 151.3 ± 3.7** 128.4 ± 2.2
* p ≤ 0.05.
** p ≤ 0.01.
*** p < 0.001.
Table 4
Acute effect of EtOAc and n-BuOH fractions on serum insulin levels (ng/ml). Values are expressed as means ± S.E.M.; n = 4 in duplicate for each treatment.
Time (min) Hyperglycemic (4 g/kg) Hyper + glipizide (10 mg/kg) Hyper
EtOAc (200 mg/kg) n-BuOH (200 mg/kg)
0 0.70 ± 0.26 – – –
15  0.77 ± 0.06 2.27 ± 0.21*** 1.55 ± 0.10*** 0.71 ± 0.10
30  0.92 ± 0.10## 1.38 ± 0.27 0.70 ± 0.04 1.11 ± 0.17
60  0.54 ± 0.04 1.03 ± 0.22* 1.70 ± 0.01*** 1.40 ± 0.40***
cemic
lycem
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t* Statistically signiﬁcant at p ≤ 0.05 compared to the respective time for hypergly
*** Statistically signiﬁcant at p ≤ 0.001 compared to the respective time for hyperg
## Statistically signiﬁcant at p ≤ 0.01 compared to zero time.
tudies on the effect of EtOAc and n-BuOH fractions of native I.
araguariensis on glycogen content
Fig. 2 shows that the liver glycogen content increased signiﬁ-
antly 3 h after glucose overload compared with fasted rats (1719%).
n addition, treatment with the n-BuOH fraction (200 mg/kg)
ncreased signiﬁcantly the glycogen content in the liver (around
5%) after 3 h of oral treatment compared to the hyperglycemic
ig. 2. Effect of n-BuOH (200 mg/kg) and EtOAc (200 mg/kg) of I. paraguariensis on
iver  glycogen content in hyperglycemic rats. Values are expressed as mean ± S.E.M.;
 = 6 in duplicate for each group. Statistically signiﬁcant at ###p ≤ 0.001 compared
o fasted normal group, ***p ≤ 0.001 compared to hyperglycemic control group. control group.
ic control group.
control group. However, the liver glycogen in hyperglycemic rats
treated with the EtOAc fraction (100 mg/kg) was  not altered com-
pared with the hyperglycemic group. Also, the glycogen content
in soleus muscle did not change after 3 h of treatment with each
fraction (data not shown).
In vitro studies on the effect of EtOAc and n-BuOH fractions of
native I. paraguariensis on disaccharidases activity
Table 5A and B shows the acute effect of the EtOAc and n-BuOH
fractions on in vitro disaccharidase activity.
Both fractions were effective in inhibiting the enzyme maltase
at all doses tested (500, 1000 and 1500 g/ml). An efﬁcient effect
of the EtOAc fraction on maltase inhibition was observed after
5 min  of intestine homogenate incubation in the presence of mal-
tose substrate. The maximum inhibitory effect of the EtOAc fraction
on maltase activity was around 35% compared with the respec-
tive control group. On the other hand, no alteration in the lactase
and sucrase enzyme activity was  detected with this fraction. The
n-BuOH fraction inhibited the maltase (by 30–35%) and the sucrase
and lactase (around 13%) activities at 5 min  of incubation.
Short- and long-term effect of EtOAc, n-BuOH fraction of native I.
paraguariensis and green and roasted mate infusions of I.
paraguariensis on AGE formation
The capacity of the EtOAc, n-BuOH fractions and the green and
roasted mate infusions to inhibit BSA glycation by glucose for
different periods is shown in Fig. 3A–C. The reduction in BSA gly-
cation by glucose observed for the EtOAc and n-BuOH fractions
increased from 7 to 28 days of in vitro incubation. At the maxi-
mum  period evaluated, more than a 50% reduction in glycation was
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Table 5
In vitro effect of EtOAc (A) and n-BuOH (B) fractions of I. paraguariensis on maltase, sucrase and lactase speciﬁc activity in the duodenum portion of rat intestine. Values are
expressed as mean ± S.E.M.; n = 6 in duplicates for each group.
Substrate Control EtOAc
500 g/ml 1000 g/ml 1500 g/ml
(A)
Maltose 0.00182 ± 0.00006 0.00121 ± 0.00003*** 0.00119 ± 000002*** 0.00128 ± 0.00005***
Sucrose 0.00125 ± 0.00004 0.00120 ± 0.00002 0.00128 ± 0.00003 0.00122 ± 0.00002
Lactose 0.00116 ± 0.00009 0.00121 ± 0.00008 0.00125 ± 0.00008 0.00121 ± 0.00008
Substrate Control n-BuOH
500 g/ml 1000 g/ml 1500 g/ml
(B)
Maltose 0.00521 ± 0.0003 0.00372 ± 0.0001** 0.00338 ± 0.0001** 0.00334 ± 0.0001**
Sucrose 0.00355 ± 0.0001 0.00308 ± 0.0001* 0.00317 ± 0.0001 0.00329 ± 0.0001
Lactose 0.00352 ± 0.0001 0.00308 ± 0.00009* 0.00311 ± 0.00008* 0.00303 ± 0.0001*
.
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2* Statistically signiﬁcant difference to the corresponding control group at p ≤ 0.05
** Statistically signiﬁcant difference to the corresponding control group at p ≤ 0.01
*** Statistically signiﬁcant difference to the corresponding control group at p < 0.00
bserved when compared with the positive glycation control group
BSA + glucose).
Fig. 4 shows the effectiveness of both fractions in inhibiting the
SA glycation by fructose over time (7–28 days). After 28 days of
n vitro incubation both fractions caused a 90% reduction in gly-
ation, compared with positive glycation control group (BSA plus
ructose). In addition, groups treated with both fractions exhibited
 similar ﬂuorescence to that observed for the BSA control group.
he EtOAc and n-BuOH fractions of I. paraguariensis were able to
nhibit albumin glycation by glucose or fructose regardless of the
oses of sugars used and the period of incubation. Considering the
esults in Figs. 3 and 4, the reduction in BSA glycation by glucose
anged from 20 to 70% and by fructose from 50 to 90% compared
ith the positive glycation control group, respectively.
As can be observed in Figs. 3 and 4, both the green and roasted
ate infusions reduced signiﬁcantly the BSA glycation by glucose
r fructose after long-term incubation (28 days). In addition, the
reen mate infusion seems to be more potent than the roasted
ate infusion in terms of reducing BSA glycation, at least in this
pproach.
iscussion
Ilex paraguariensis has been reported to be rich in a series of com-
ounds with signiﬁcant biological activities that highlight this plant
s an interesting example of ethnopharmacology. The characteri-
ation and content of methyl xanthines (caffeine and theobromine)
nd polyphenols in both samples (native sample from Santa Maria
nd commercial samples) are in line with those widely reported
n the literature for I. paraguariensis St. Hil.var. paraguariensis
Aquifoli-aceae) (Bastos et al. 2006; Cardozo-Junior et al. 2007).
A single oral administration with the EtOAc or n-BuOH fraction
aused a signiﬁcant decrease in serum glucose levels in hyper-
lycemic normal rats at both doses studied. Considering both the
mprovement effect for the two fractions on the oral glucose toler-
nce curve and no inﬂuence on serum glucose-lowering in diabetic
ats, observed in this approach, our hypothesis is that the hypo-
lycemic mechanism involves an insulin–secretagogue compound
resent in these fractions. Methyl xanthines and polyphenols have
een attributed a role in many of the pharmacological activities of
erba mate. It seems clear that the biological activity can be related
ith the amount of compound present into the samples.
In fact, we have previously demonstrated the strong anti-
yperglycemic or insulin–secretagogue action of several classes
f compounds like C-glycosilated ﬂavonoids (Cazarolli et al.
009; Folador et al. 2010), nitrochalcones and naphthyl chalcones(Damazio et al. 2009, 2010). The high amount of catechin and
chlorogenic acid were found on EtOAc fraction and green infu-
sion. Taking it in account, both compounds seem to be responsible
for antihyperglycemic activity observed. Based on these ﬁnd-
ings, we carried out some in vivo treatments to verify the acute
effect of the EtOAc and n-BuOH fractions on insulin secretion.
These original ﬁndings regarding the role of both fractions as an
insulin–secretagogue corroborate the effect of these fractions on
the serum glucose-lowering demonstrated by the oral glucose tol-
erance curve. The time-course proﬁle of insulin secretion induced
by EtOAc, which in this approach showed the powerful effect of
glipizide (70%), indicates that this fraction may regulate the ﬁrst
and second phases of insulin secretion. As far as we  known, this is
the ﬁrst demonstration of insulin secretion after an acute treatment
with fractions of I. paraguariensis in hyperglycemic rats.
The demonstration of the stimulatory effect of the n-BuOH frac-
tion on glycogen content in the liver and also the absence of an
effect on glycogen accumulation in soleus muscle for this fraction
indicates an additional and expressive role of I. paraguariensis in
managing glucose in order to ameliorate the glucose postprandial
state. The contrasting effect of the EtOAc fraction on the hepatic
glycogen content compared with the n-BuOH fraction reinforces
the suggestion that active compounds able to modify signiﬁcantly
the glucose stocks are present in the n-BuOH fraction. We  recently
reported the stimulatory effect of some ﬂavonoids isolated from the
n-BuOH fraction as well as their potential effect on insulin secretion
(Folador et al. 2010). Overall, these data corroborate the enhanced
beneﬁts of I. paraguariensis in protecting against glucose imbal-
ance. Along with the ongoing traditional use of mate beverages,
I. paraguariensis can be considered one of the most highly con-
sumed drinks in various South American countries, with an average
ingestion of 1–2 l per day or 6–8 kg/person/year (De  Morais et al.
2009).
The ability of the EtOAc and n-BuOH fractions to inhibit in vitro
disaccharidase activity was  observed as a very short-term effect
after duodenum incubation. Although the maximum inhibition of
maltase activity for the EtOAc fraction was around 35% compared
with control group, these results are in line with the remarkable
effect of puriﬁed quercetin recently published by our group (Pereira
et al. 2011). Thus, an important gateway to glucose, the intestine,
might be regulated by I. paraguariensis compounds contributing
to glucose homeostasis. It is worth noting that in the duodenum
glucose transporters (SGLT-1, GLUT-2) may  also be affected by I.
paraguariensis, as previously demonstrated for some isoﬂavone glu-
cosides (Meezan et al. 2005). Thus, both the activity and nuclear
expression of these proteins merit in-depth study.
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Fig. 3. Effects of EtOAc and n-BuOH fractions and green and roasted infusions of I.
paraguariensis on ﬂuorescent derived from AGE formation after 7 (A), 14 (B) and 28
(C)  days of incubation with glucose at the indicated concentrations of each fraction.
BSA  (5 mg/ml) was  incubated with glucose (500 mM)  in PBS (pH 7.4) containing
0.02% sodium azide at 37 ◦C. AGE ﬂuorescence was measured by characteristic ﬂu-
orescence (excitation wavelength of 370 nm and emission wavelength of 440 nm)
in  aliquots of each reaction mixture. Statistically signiﬁcant difference to the corre-
sponding positive control group (BSA + glucose) at *p ≤ 0.05; **p ≤ 0.01; ***p < 0.001.
Fig. 4. Effects of EtOAc and n-BuOH fractions and green and roasted infusions of I.
paraguariensis on ﬂuorescent derived from AGE formation after 7 (A), 14 (B) and 28
(C) days of incubation with fructose at the indicated concentrations of each extract.
BSA (5 mg/ml) was  incubated with fructose (100 mM)  in PBS (pH 7.4) containing
0.02% sodium azide at 37 ◦C. AGE ﬂuorescence was measured by characteristic ﬂu-
orescence (excitation wavelength of 370 nm and emission wavelength of 440 nm)
in  aliquots of each reaction mixture. Statistically signiﬁcant difference to the corre-
sponding positive control group (BSA + fructose) at *p ≤ 0.05; **p  ≤ 0.01; ***p < 0.001.
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Advanced glycation end-products contribute signiﬁcantly to the
athophysiology of chronic aging and diabetic complications (Xue
t al. 2011). The considerable acute effect of the EtOAc and n-BuOH
ractions of the native I. paraguariensis and the infusions of the
reen and roasted commercial source on serum glucose-lowering
as observed from 15 to 60 min  after in vivo treatment, under
hese experimental conditions. To extend this investigation, we
ecided to employ an in vitro approach able to reproduce short
nd long-term effects of the samples from different sources on the
ormation of AGEs. In this regard, BSA glycation by glucose or fruc-
ose was used to assay the effect of I. paraguariensis fractions and
nfusions after 7, 14 and 28 days of in vitro incubation. The pro-
le of the inhibition of BSA glycation by glucose by the fractions
nd infusions was time-dependent but no signiﬁcant differences
ere observed between fractions or plant samples (native and com-
ercial). Although the AGE ﬂuorescence was higher for the BSA
lycation by fructose than by glucose, a remarkable anti-glycation
ffect of the samples from different sources (native and commer-
ial) was exhibited according to the treatment time.
It is well known that in several different oxidative systems
ncluding transition metal ions, free radical generators can occur
n glycation pathways and antioxidant compounds commonly
resent in the diet may  act as anti-glycation compounds (Bracesco
t al. 2003; Gugliucci et al. 2009). Methyl xanthines present in I.
araguariensis are known as a class of compounds with many phar-
acological activities and the potential antioxidant power of this
lant compared with green and black tea or red wine has also been
reviously reported (Bixby et al. 2005). Considering together these
nteresting results concerning the anti-glycation role of I. paraguar-
ensis, as a very short- and long-term effect of in vitro treatment, this
lant represents a new target that merits investigation since the
onsumption of chimarrão and mate tea can ameliorate the diabetes
tatus. Studies are underway in order to understand the mechanism
f action of the EtOAc, n-BuOH fractions of native I. paraguarien-
is and green and roasted infusions from a commercial source in
nducing signiﬁcant glycation inhibition.
onclusions
The results of this study showed that both the EtOAc and n-
uOH fractions of native I. paraguariensis and the infusions of green
nd roasted I. paraguariensis from a commercial source were able
o ameliorate diabetes status since a signiﬁcant glucose tolerance
mprovement was observed, the liver glycogen was  stocked, disac-
haridases were signiﬁcantly inhibited and protein glycation was
ramatically reduced in the presence of the fractions or infusions.
lso, there was notable insulin secretion which corroborates the
ole of I. paraguariensis in serum glucose-lowering. It is worth not-
ng that I. paraguariensis contains compounds that can act at speciﬁc
ites to modulate exogenous glucose absorption, glucose utilization
y the body, and serum glucose imbalance.
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